Manufacturing Controlled Substances

Article

David Mayers, president of Wellspring Pharma Services sat down with Pharmaceutical Technology to discuss the manufacture of controlled substances. 

 

 

Recent Videos
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Site Logo

Bringing Gene Therapies to Market

August 1st 2019
Article

Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.

Site Logo

Gene Therapy Production Must Pass Regulatory Hurdles

August 1st 2019
Article

Mass-produce cell and gene therapies presents the biopharma industry with a unique set of challenges.

Site Logo

CPhI 2016 Excellence in Pharma: Packaging Award Winner Interview

January 3rd 2017
Article

Pylote SA discusses its Pyclear Protection packaging innovation.

Site Logo

Improving Regulatory Compliance

December 1st 2016
Article

Andrew Bulpin, head of Process Solutions Strategic Marketing and Innovation, MilliporeSigma discusses the company's Emprove Program, winner of the 2016 CPhI Award for Regulatory Procedures and Compliance. 

Site Logo

Minitablets in Pharma Manufacturing

June 29th 2016
Article

Site Logo

Handling High Potency APIs

June 27th 2016
Article